Avoro Capital Advisors 13F: Exits AUTL Stake

Avoro Capital Advisors has completely exited its position in AUTL, according to its latest 13F filing with the SEC. The fund sold all 9,910,642 shares it previously held, leaving it with no remaining stake. This move represents a 100% reduction in its holdings.

What Changed in Avoro Capital Advisors' AUTL Position

Avoro Capital Advisors sold its entire holding of 9,910,642 shares in AUTL, reducing its stake to zero. This complete exit marks a significant change from its previous position, where the fund held nearly 10 million shares.

Other Institutional Activity in AUTL

Other institutional investors have shown varied interest in AUTL. MAK Capital One LLC increased its holdings by 3,616,144 shares, bringing its total to 33,621,487 shares valued at approximately $46.4 million. Blackstone Inc. maintained its position with 20,485,611 shares worth about $28.3 million. Meanwhile, Armistice Capital, LLC reduced its holdings by 1,700,000 shares, ending with 15,800,000 shares valued at $21.8 million.

Autolus Therapeutics plc Stock Down 19.6%

Shares of AUTL traded at $1.56. The stock's performance and market dynamics are of interest to investors and analysts alike, especially following Avoro Capital Advisors' recent exit.

Insider Buying and Selling at Autolus Therapeutics plc

Insider Martin Pule sold 698,741 shares on September 16, 2024, at an average price of $4.00 and $4.23 per share, under a planned Rule 10b5-1 trading plan.

Analysts Set New Price Targets

Analysts remain optimistic about AUTL. On May 14, 2026, HC Wainwright & Co. maintained a 'buy' rating with a $10 price target. Similarly, Mizuho and Needham reiterated their 'buy' ratings with the same target. Wells Fargo also maintained a 'buy' rating with a lower target of $5.

About AUTL

AUTL operates in the biotechnology sector, focusing on the development and commercialization of innovative therapies. The company is involved in advancing treatments for various diseases, leveraging its proprietary technology platform.

Bottom Line

Avoro Capital Advisors' decision to sell its entire stake in AUTL is a notable move, reflecting its updated investment strategy. Investors often track such changes to gauge market sentiment, though 13F filings are historical and may not represent current positions. AUTL continues to attract attention from other institutional investors and analysts maintaining positive ratings.